Skip to main content
CFR
NYSE Finance

Cullen/Frost Bankers Appoints Two New Directors, Expands Board

Analysis by Wiseek AI
Sentiment info
Neutral
Importance info
7
Price
$135.45
Mkt Cap
$8.661B
52W Low
$100.31
52W High
$146.44
Market data snapshot near publication time

Summary

Cullen/Frost Bankers announced the appointment of two new independent directors, Marsha M. Shields and Jeffrey M. Rummel, and an expansion of its board from thirteen to fifteen members, while Dr. Chris Avery will retire at the upcoming annual meeting.


Key Events

  • Two New Directors Appointed

    Marsha M. Shields, CEO of McCombs Enterprises, and Jeffrey M. Rummel, former Managing Partner at Ernst & Young, were elected to the Board of Directors, effective immediately.

  • Board Size Expanded

    The Board of Directors was expanded from thirteen to fifteen members to accommodate the new appointments.

  • Key Expertise Added

    Mr. Rummel brings over 37 years of experience in financial services audit and risk assessment, which is highly relevant for the company's Audit and Risk Committees.

  • Director Retirement Announced

    Dr. Chris Avery will retire and not stand for re-election when his term expires at the 2026 Annual Meeting of Shareholders on April 29, 2026.


Analysis

Cullen/Frost Bankers has strengthened its board with the appointment of two highly experienced directors, Marsha M. Shields and Jeffrey M. Rummel, and expanded its board size. Mr. Rummel's extensive background as a former managing partner at Ernst & Young, with over 37 years in financial services audit and risk assessment, is particularly valuable for a financial institution and enhances the company's governance and oversight capabilities, especially on the Audit and Risk Committees. Mrs. Shields brings significant leadership experience from McCombs Enterprises and various board roles. The planned retirement of Dr. Chris Avery is a routine transition.

At the time of this filing, CFR was trading at $135.45 on NYSE in the Finance sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $100.31 to $146.44. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CFR - Latest Insights

CFR
Apr 30, 2026, 5:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $144.93
Real-time Price: $148.00 info
Change: +$3.07 (+2%) info
Market Cap: $9.294B info
CFR
Apr 30, 2026, 9:20 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $142.80
Real-time Price: $148.00 info
Change: +$5.20 (+4%) info
Market Cap: $9.294B info
CFR
Feb 11, 2026, 11:28 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $147.35
Real-time Price: $148.00 info
Change: +$0.650 (+0.44%) info
Market Cap: $9.294B info
CFR
Feb 05, 2026, 3:51 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $143.39
Real-time Price: $148.00 info
Change: +$4.61 (+3%) info
Market Cap: $9.294B info
CFR
Jan 30, 2026, 12:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $135.45
Real-time Price: $148.00 info
Change: +$12.55 (+9%) info
Market Cap: $9.294B info
CFR
Jan 29, 2026, 9:55 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $135.58
Real-time Price: $148.00 info
Change: +$12.42 (+9%) info
Market Cap: $9.294B info